Login
From:
Synox | Website
(Uncensored)
subscribe
SynOx Therapeutics announces $75m Series B round to fund Phase 3 trial of potential best-in-class treatment for TGCT
https://synoxtherapeutics.com/synox-therapeutics-announces-75m-series-b-round-to-fund-phase-3-trial-of-potential-best-in-class-treatment-for-tgct/
links
backlinks
Financing co-led by Forbion, HealthCap and new investor Bioqube Ventures
Roast topics
Find topics
Find it!
